AAV Intein Retinal Gene Therapy for Stargardt Disease is Effective and Safe in Large Animal Models

被引:0
|
作者
Trapani, Ivana [1 ,2 ]
Ferla, Rita [3 ]
Pugni, Eugenio [1 ]
Lupo, Mariangela [1 ]
Perota, Andrea [4 ]
Gesualdo, Carlo [5 ]
Rossi, Settimio [5 ]
Simonelli, Francesca [5 ]
Bacci, Maria Laura [6 ]
Galli, Cesare [4 ]
Memon, Ali [3 ]
Shams, Naveed [3 ]
Auricchio, Alberto [1 ,2 ,3 ]
机构
[1] Telethon Inst Genet & Med, Pozzuoli, Italy
[2] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy
[3] AAVantgarde Bio Srl, Milan, Italy
[4] Avantea, Lab Reprod Technol, Cremona, Italy
[5] Univ Campania Luigi Vanvitelli, Multidisciplinary Dept Med Surg & Dent Sci, Eye Clin, Naples, Italy
[6] Univ Bologna, Dept Vet Med Sci, Ozzano Dellemilia, Italy
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
297
引用
收藏
页码:158 / 159
页数:2
相关论文
共 50 条
  • [1] Retinal gene therapy for Stargardt disease with dual AAV intein vectors is both safe and effective in large animal models
    Ferla, Rita
    Pugni, Eugenio
    Lupo, Mariangela
    Tiberi, Paola
    Fioretto, Federica
    Perota, Andrea
    Duchi, Roberto
    Lagutina, Irina
    Gesualdo, Carlo
    Rossi, Settimio
    Ventrella, Domenico
    Elmi, Alberto
    Mcclinton, Benjamin
    Toomes, Carmel
    Xu, Tongzhou
    Molday, Robert S.
    Surace, Enrico M.
    Simonelli, Francesca
    Bacci, Maria L.
    Galli, Cesare
    Memon, Muhammad A.
    Shams, Naveed
    Auricchio, Alberto
    Trapani, Ivana
    SCIENCE ADVANCES, 2025, 11 (13):
  • [2] AAV-Mediated Gene Therapy for Retinal Disorders in Large Animal Models
    Stieger, Knut
    Lheriteau, Elsa
    Moullier, Philippe
    Rolling, Fabienne
    ILAR JOURNAL, 2009, 50 (02) : 206 - 224
  • [3] Preclinical safety and efficacy of intein-based dual-AAV gene therapy for Stargardt disease
    Favre, David
    Di Scala, Marianna
    Aisa, Izarbe
    Abad, Victor
    Calles, Gerard
    Esteve-Rudd, Julian
    Frutos, Silvia
    Vila-Perello, Miquel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [4] Preclinical Safety and Efficacy of Intein-Based Dual-AAV Gene Therapy for Stargardt Disease
    Vila-Perello, Miquel
    Di Scala, Marianna
    Aisa, Izarbe
    Abad, Victor
    Caelles, Gerard
    Esteve Rudd, Julian
    Frutos, Silvia
    Favre, David
    MOLECULAR THERAPY, 2024, 32 (04) : 333 - 333
  • [5] Gene Therapy in a Novel Large Animal Model of Stargardt Disease
    Trapani, Ivana
    Pugni, Eugenio
    Lupo, Mariangela
    Iodice, Carolina
    Gesualdo, Carlo
    Rossi, Settimio
    Ventrella, Domenico
    Simonelli, Francesca
    Bacci, Maria Laura
    Galli, Cesare
    Auricchio, Alberto
    MOLECULAR THERAPY, 2020, 28 (04) : 2 - 2
  • [6] Gene therapy in a novel large animal model of Stargardt disease
    Pugni, E. N.
    Tiberi, P.
    Lupo, M.
    Iodice, C.
    Gesualdo, C.
    Rossi, S.
    Simonelli, F.
    Bacci, M. L.
    Galli, C.
    Auricchio, A.
    Trapani, I.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A72 - A72
  • [7] Gene therapy in a novel large animal model of Stargardt disease
    Pugni, Eugenio Nahuel
    Lupo, Mariangela
    Iodice, Carolina
    Gesualdo, Carlo
    Rossi, Settimio
    Simonelli, Francesca
    Bacci, Maria Laura
    Galli, Cesare
    Auricchio, Alberto
    Trapani, Ivana
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 73 - 74
  • [8] Selective Intein Degradation for Safe AAV Mediated Large Gene Delivery
    Tornabene, Patrizia
    Centrulo, Miriam
    Auricchio, Alberto
    MOLECULAR THERAPY, 2020, 28 (04) : 404 - 404
  • [9] AAV-mediated gene therapy for retinal disorders in large animal models (vol 50, pg 206, 2009)
    Stieger, K.
    Lheriteau, E.
    Moullier, P.
    Rolling, F.
    ILAR JOURNAL, 2009, 50 (03) : E1 - E1
  • [10] A novel dual AAV approach for intravitreal gene therapy of Stargardt disease
    Mehlfeld, V.
    Splith, V.
    Bartoschek, M.
    Pandurangi, J.
    Boehm, S.
    Riedmayr, L. M.
    Michalakis, S.
    Biel, M.
    Becirovic, E.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A26 - A26